Clinical Software in California

Monobind Inc. is a leading independent in vitro diagnostics (IVD) manufacturer founded in 1978 and headquartered in Lake Forest, California. The company develops and manufactures over 160 immunoassay products across its AccuBind® ELISA and AccuLite® CLIA platforms, serving clinical laboratories, point-of-care facilities, and direct-to-patient applications globally. Monobind's portfolio spans multiple assay formats—microplate, monotest, magnetic-bead, lateral flow assays (LFA), and microarray technologies—enabling testing of serum, plasma, and whole blood samples. The company supports scalable workflows from manual reader-based systems to fully automated random-access analyzers. Beyond finished assays, Monobind supplies high-quality biomaterials and specialty reagents including buffers and stabilizers for the global diagnostics industry. Operating under FDA registration and ISO 13485 certification, the company distributes CE-marked products to laboratories and partners in over 100 countries worldwide.

Amphenol DC Electronics (ADCE) is a custom cable assembly and wire harness manufacturing company established in 1979 and acquired by Amphenol in 2013. Headquartered in San Jose, CA with facilities in Nogales Mexico, Penang Malaysia, and additional Mexican operations, ADCE manufactures custom wire harnesses, cable assemblies, integrated electrical-mechanical devices (box builds), overmolded cable assemblies, and discrete assemblies. The company serves aerospace/defense, medical equipment, industrial, and agricultural sectors. For medical applications, ADCE produces cable assemblies and interconnect systems for MRI and CT imaging equipment, patient monitoring devices, surgical robotics, life support systems, and laboratory equipment. Manufacturing capabilities include in-house CNC tooling and molding (30, 55, 85-ton presses), custom overmolding with specialized materials, smart cable design, RF coaxial and semi-rigid coax assemblies, fiber optic cables, and prototype-to-production services. The company holds ISO 13485:2016 certification for medical device manufacturing, IPC-620 Class III certification, UL508 and UL764 certifications, FDA registration, and maintains ITAR, SAM, GDEP, and C-TPAT compliance for defense work. ADCE employs 300+ personnel across its Silicon Valley headquarters (70,000 sq ft) and operates a mature global supply chain with MRP processing, supplier contract pricing, and kanban inventory management.

TICKERWORKS, INC. manufactures precision pharmaceutical compounding and unit-dose drug packaging solutions for human and veterinary pharmacy applications. The company specializes in innovative applicators, dispensers, and molds designed to improve accuracy, reduce waste, and enhance medication delivery. Core product lines include TICKER® click dispensers for transdermal and topical applications, TROCHE POPS® unit-dose pods for sublingual troches, Pebble Beach and RDT molds for rapid-dissolving tablets and troches, suppository molds in various formulations, and compounding kits. The company also offers lab equipment including centrifuges. TICKERWORKS serves compounding pharmacies, veterinary clinics, and compounding professionals, with particular focus on hormone specialists and animal health practitioners. The organization is ISO 9001 certified and FDA registered, indicating compliance with quality management and regulatory standards for pharmaceutical manufacturing. Products emphasize accuracy, eco-friendly design (30% less plastic than comparable dispensers), and ease of use for pharmacy professionals. The company participates actively in professional conferences including ACVP, WVC, and industry owner summits, indicating strong market positioning within pharmacy and veterinary communities.

CloudCath is a digital health medical device company that develops remote monitoring solutions for peritoneal dialysis (PD) patients. The company's flagship product, CloudCath Connect™ PD, is an add-on device for PD cyclers that utilizes optical analysis, IoT sensors, machine learning, and cloud computing to measure turbidity in dialysate effluent. By quantifying fluid analysis rather than relying on subjective visual assessment, CloudCath enables early detection of peritonitis and other complications—on average 3.1 days before patient-reported symptoms. Clinical evidence demonstrates a 45% reduction in peritonitis-related hospitalization and 56% reduction in catheter loss. The system seamlessly integrates with major PD cyclers (Baxter and Fresenius), provides real-time notifications to patients and clinicians, and supports continuous home-based monitoring to shift care from in-center facilities. This innovative approach enhances patient outcomes, improves therapy adherence, and reduces the need for emergency interventions in end-stage renal disease management.

Jazz Imaging manufactures intraoral dental X-ray sensors and dental imaging software. The company produces two primary sensor product lines: SOLO (Size 2 imaging with Size 1 comfort) and MINOR (Size 1 imaging with Size 0 comfort), both utilizing premium CMOS technology to deliver high-quality radiographs with superior resolution and low-dose imaging optimization. Jazz sensors feature a high active area ratio, slim and comfortable patient-facing design, and are designed for seamless integration with major dental imaging software platforms without TWAIN protocol limitations. The company also offers Classic, a proprietary dental imaging software suite built in-house, available free to Jazz sensor users, providing intuitive exam templates, full-mouth X-ray (FMX) functionality, and straightforward EHR/practice management software integration. Jazz Imaging emphasizes direct-from-manufacturer sales with transparent pricing, offering both subscription (Jazz Club membership starting at $119/month with $498 activation) and traditional purchase options ($5,299 standalone sensor purchase). All sensors include lifetime warranty support, fast sensor replacement, and 30-day money-back guarantee. Products are manufactured in the USA with no import tariffs. The company serves dental practices ranging from solo practitioners to multi-office organizations and positions itself as a cost-effective alternative to incumbent dental sensor brands while maintaining diagnostic image quality and patient comfort standards.

RENPHO is a global consumer wellness technology brand founded in 2016, headquartered in California with international offices. The company specializes in connected smart health devices and wearables that enable individuals to track and optimize personal health metrics through advanced body composition analysis, vital sign monitoring, and recovery/wellness solutions. Core product categories include smart body composition scales (MorphoScan series using DF-BIA technology), wearable health tracking devices (LYNX smart ring, smart tape measures), eye and foot massage systems, therapeutic massage guns with temperature control, air compression recovery boots, and beauty/aesthetic devices (LED light therapy masks). All devices integrate with RENPHO's free Health App ecosystem, which serves 20M+ users globally with data analytics, goal tracking, and community features. Products are FSA/HSA eligible and clinically validated, with distribution across 100+ countries. The brand targets health-conscious consumers, fitness enthusiasts, and individuals managing chronic health conditions through accessible, app-connected health monitoring technology.

VivoSense Inc. is a wearable sensor Contract Research Organization (CRO) specializing in digital health technology (DHT) for clinical trials. Founded 14+ years ago, the company provides end-to-end wearable sensor services across 20+ therapeutic areas, serving pharmaceutical sponsors, contract research organizations, and digital health innovators in 30+ countries. The company's core offering includes DHT strategy consultation, wearable device selection and vendor management, protocol development, data collection operationalization, data cleaning and analysis, and clinical validation. VivoSense operates a proprietary DHT platform designed for compliance and auditability in clinical trial environments. The platform enables collection and processing of high-volume, complex sensor data into structured, actionable insights. The company has deployed 70+ wearable sensors to date across diverse disease areas. Clinical operations and data science teams leverage decades of combined experience in digital health technology implementation and sensor data analytics. Recent regulatory engagement includes qualification discussions with the European Medicines Agency (EMA) regarding MEADOW-RETT-BR, a DHT-based measure of apnea events in Rett syndrome patients. Notable partnerships include Biogen, Roche, argenx, Mayo Clinic, and GSK. Services span three phases: study startup (DHT strategy and measure selection), study conduct (operationalization and data collection), and study closeout (data investigation and statistical validation).

Tristel Solutions Limited is a global healthcare infection control company specializing in high-level disinfection solutions for medical devices and healthcare surfaces. With over 30 years of industry experience, the company manufactures chlorine dioxide-based disinfectants and digital compliance platforms serving hospitals, clinics, and medical facilities worldwide. The company operates three primary business lines: (1) Tristel brand—high-level disinfectant solutions for medical device decontamination using chlorine dioxide technology; (2) Cache—surface disinfection systems leveraging sporicidal chlorine dioxide formulations; and (3) 3T—a digital traceability and compliance platform integrating with Tristel's disinfection products to provide audit trail documentation and training management. Tristel's products address infection prevention and healthcare-associated infection (HAI) reduction, with demonstrated efficacy against biofilms, spore-forming bacteria (Clostridioides difficile), and emerging pathogens. The company emphasizes sporicidal claims validated against European Norms (EN standards), including EN 17846 certification for sporicidal disinfectant evaluation. Products include the Tristel Trio Wipes System (point-of-care medical device decontamination), Tristel DUO ULT and DUO OPT formulations, Fuse for Medical Surfaces, and JET LUXE and JET PRO delivery systems. Tristel provides comprehensive support services including technical training, product validation, research and development expertise, and after-sales customer support. The company serves diverse healthcare departments including endoscopy, central sterile supply (CSSD), surgery, cardiology, and infection control. Manufacturing and operations are based in the United Kingdom with global distribution capabilities.

JAM-Labs Corp is a medical technology company specializing in AI-powered surgical environment solutions and operating room integration systems. The company designs and manufactures hardware, software, FPGA, embedded systems, and mechanical solutions for perioperative environments. Their product portfolio includes advanced OR recording and visualization devices, integration systems, and intelligent digital platforms that enhance surgical workflows, patient safety, and OR efficiency. JAM-Labs serves hospitals and surgical centers with solutions designed for surgeons, nursing staff, trainees, and healthcare administrators. The company emphasizes real-time data insights, automation through AI algorithms, error prevention systems, and seamless integration with existing perioperative workflows. Their offerings address OR performance optimization, staff collaboration, surgical documentation, and procedure recording with high-resolution 4K visualization. JAM-Labs targets institutional healthcare markets and has demonstrated presence in catheterization labs and surgical suite environments, with customer testimonials from hospital networks and specialized surgical centers.

GenDx is a science-based molecular diagnostics company specializing in HLA typing and transplantation diagnostics. The company develops and markets pre- and post-transplant reagent kits, NGS-based HLA typing solutions, and proprietary laboratory software for clinical diagnostics. Product lines include NGSgo-AmpX (next-generation sequencing HLA typing kits for various gene targets including HLA-DRB1, DQB1, and DPB1) and complementary software platforms known for reliability, intuitive navigation, and rapid analysis. GenDx serves transplant laboratories, biobanks, and research institutions globally, with particular emphasis on user-friendly workflows and technical support. The company offers world-class customer support, educational events, and training programs for end users at all proficiency levels. GenDx appears to operate as part of a larger acquisition ecosystem, as evidenced by recent press releases regarding CareDx's transplant lab product division. The company maintains a strong focus on molecular diagnostics quality, laboratory efficiency, and continuous innovation in companion diagnostics and precision medicine applications.

CareDx is a transplant-focused diagnostic and digital health company providing comprehensive solutions across the entire transplant journey. The company delivers advanced diagnostics including rejection monitoring tests and HLA typing kits, digital health platforms, and transplant pharmacy services. CareDx reports performing over 1 million rejection monitoring tests annually, selling approximately 200,000 HLA typing kits per year, and filling 150,000 prescriptions through its transplant pharmacy division. The platform serves approximately 70% of transplant centers with one or more software products. Products and solutions span diagnostic testing, digital workflow platforms, lab innovations, and clinical decision support tools. The company combines laboratory testing capabilities with software platforms designed to simplify clinical workflows and personalize patient care throughout transplant management. CareDx operates as an integrated provider offering both diagnostic services and digital health infrastructure for transplant programs, including pre-transplant evaluation, post-transplant monitoring, and rejection surveillance.

BioIntelliSense develops continuous patient monitoring systems for in-facility and home care settings. The company's flagship product, the BioButton wearable device, captures multiparameter vital signs and biometric data in real time, enabling proactive detection of patient deterioration. The system integrates flexible connectivity options (BioMobile app, BioHub Cellular gateway, BioHub Wi-Fi gateway) with BioDashboard clinical intelligence software for exception-based monitoring and analysis. Clinical studies demonstrate that continuous monitoring reduces unplanned ICU admissions, rapid response team activations, and average length of hospital stay. The platform supports operational efficiency initiatives including length-of-stay reduction, virtual rounding optimization, and telemetry overuse reduction. BioIntelliSense targets hospitals, health systems, skilled nursing facilities, assisted living, home health agencies, and remote patient monitoring providers. The company emphasizes evidence-based outcomes from peer-reviewed publications, including research in the Journal of Clinical Medicine and British Journal of Anaesthesia. Products are designed for both acute care floor monitoring and post-acute care transitions, with reimbursement support for remote patient monitoring (RPM) programs. The system is described as medical-grade and designed for healthcare provider organizations only, not direct consumer purchase.

Persyst Development LLC is the worldwide leader in EEG (electroencephalography) software for clinical neurodiagnostics. The company develops and markets Persyst 15 (P15), a comprehensive Computer Assisted Review of EEG (C.A.R.E) platform that provides advanced tools for EEG data review, analysis, and monitoring. Core capabilities include automated seizure detection, spike detection, artifact reduction, and EEG trending analytics designed to support both high-volume institutions and community clinics. Persyst's seizure detection algorithm has been validated in peer-reviewed literature (Journal of Clinical Neurophysiology) as statistically noninferior to skilled human reviewers. The company also offers Persyst Mobile, the first FDA-cleared EEG monitoring and review application for mobile devices, enabling remote access to EEG data. Persyst is integrated with and sold/supported by every major EEG hardware manufacturer, including Micromed, Natus, Nihon Kohden, Cadwell, and Compumedics. The software is recognized as the standard of care, with adoption at 211 of 233 US News-ranked neurology and neurosurgery centers. The company maintains a strong commitment to clinical research and scientific validation, publishing findings in peer-reviewed journals and hosting educational events such as Persyst Grand Rounds.

Besmile is a dedicated manufacturer of dental CAD/CAM materials, digital equipment, and implant systems serving dental laboratories and practices. The company specializes in in-house development and production of high-quality dental zirconia blanks (including multilayer and gradient-shade formulations), glass ceramics, dental coloring solutions, stain and glaze materials, and precision dental equipment. Core product lines include the BSM-520D 5-axis milling machine with 60,000 RPM spindle, 3D dental printers, sintering furnaces, and implant systems. The company emphasizes advanced manufacturing technology, persistent R&D, reliable raw materials, and quality assessment protocols. Besmile serves the digital dentistry workflow, particularly for prosthetic dentistry and implantology applications. The company participates in major dental trade shows (SIDEX, Birmingham Dentistry Show, LMT Labday West) and has received innovation recognition. Products are marketed under brand names including Aconia for zirconia materials and BSM Smile Designer for abutment design software. The company operates with quality control standards and serves an international customer base of dental laboratories and practices seeking cost-effective, high-performance CAD/CAM solutions.

Trademark Plastics Inc is a vertically integrated contract manufacturer specializing in precision plastic injection molding for the healthcare, pharmaceutical, diagnostics, and consumer products sectors. Founded in 1989, the company operates a 100,000 sq. ft. facility in Riverside, CA with 51 injection molding machines (6–610 ton capacity), 2 ISO Class 8 cleanrooms, and 2 controlled white rooms. TPI provides full turnkey solutions including plastic injection molding, rapid prototyping (5-day turnaround), mold design, tooling, and value-added services. Primary markets are medical device OEMs, IVD manufacturers, pharmaceutical companies, and diagnostic device makers. The company manufactures custom medical components, IVD supplies, lab supplies, and consumer products. TPI holds ISO 9001 and ISO 13485 certifications and operates in compliance with FDA regulations and MDR requirements, producing biocompatible and sterile-ready components. The company maintains operations in both the USA and China. Over 100 employees support design-for-manufacturability, precision tolerances, and lifecycle support for medical-grade plastic components.

Apical Instruments is a medical device design, engineering, and manufacturing company specializing in electrosurgical generators and related medical RF systems. Based in Redwood City, California, Apical provides end-to-end product development services including proof-of-concept evaluation, prototype development, design validation, and full-scale manufacturing. The company maintains ISO 13485 Design Control processes and FDA Quality System compliance, with expertise in regulatory submissions (FDA 510(k), European notified body audits) and medical device patents. Apical serves biotechnology and medical device firms seeking to streamline development timelines while ensuring quality and regulatory compliance from inception through production and ongoing support.

Illumina, Inc. is a global leader in DNA sequencing and array-based genomic analysis, providing comprehensive solutions for research, clinical diagnostics, and precision health applications. The company manufactures next-generation sequencing (NGS) platforms ranging from benchtop to production-scale instruments, microarray systems for genetic analysis, and library preparation kits optimized for diverse DNA and RNA workflows. Illumina's product portfolio includes the TruPath Genome solution, Single Cell 3' RNA Prep kits, and associated bioinformatics software for data analysis and insights. The company serves academic research institutions, clinical laboratories, pharmaceutical companies, and healthcare providers globally, enabling applications in cancer research, genetic disease testing, infectious disease surveillance, reproductive health, and precision medicine. Illumina offers 24/7 technical support, comprehensive documentation, training resources, and multiple financing options for instrument acquisition. The company maintains regulatory compliance with FDA clearances and international standards, and provides worldwide distribution through channel partners and direct sales. Corporate headquarters located in San Diego, CA with regional offices and support centers across North America, Europe, Asia-Pacific, and other global markets.

DCN Dx is a contract development and manufacturing organization (CDMO) and contract research organization (CRO) specializing in rapid point-of-care diagnostic tests, particularly lateral flow assays and in vitro diagnostics (IVD). Founded in 2006 and based in Carlsbad, California, DCN Dx operates a 35,000+ sq. ft. ISO 13485- and ISO 9001-compliant facility with advanced development labs including a 6,626 sq. ft. BSL-2 lab, dry room capability, and aseptic manufacturing suites. The company provides end-to-end services spanning contract assay development, custom reader design, consumable and cassette design, contract manufacturing, clinical validation, regulatory consulting, and IVD clinical trial management including trial setup, site development, biostatistics, and data management. DCN Dx also offers prospective biospecimen collection services and hosts training courses on lateral flow technology. Their multidisciplinary team works with diagnostics companies, biotech firms, and government-funded research programs to accelerate development from early-stage assay design through clinical validation and manufacturing scale-up.

Hinge Health is a digital musculoskeletal (MSK) and pelvic health care company delivering virtual physical therapy, personalized exercise programs, and FDA-cleared waveform-based pain relief technology. The company operates a comprehensive digital-first platform combining 3D motion-tracking guided exercise sessions, care team coordination (physical therapists, health coaches, orthopedic specialists, and AI care assistant), and the Enso® device—an FDA-cleared, drug-free pain relief device using proprietary waveforms. Services are delivered through the Hinge Health app with real-time feedback and precision movement analysis. The platform addresses chronic joint and muscle pain, including specialized virtual pelvic floor therapy. Hinge Health serves employers and health plans with value-based pricing, seamless integration across 5 major national health plans and 3 PBMs, and independently validated outcomes demonstrating 2.4x hard dollar ROI. The care model emphasizes frictionless implementation and contracting with partner-enabled eligibility, billing, and care coordination workflows.

Movano Health is a wearable medical device company specializing in personalized health monitoring technology. The company develops smart rings and wearable sensors featuring patented radio frequency (RF) technology for non-invasive, cuffless vital sign monitoring including blood pressure, glucose levels, and pulse oximetry. The Evie Ring is designed for women's health with trend tracking and Apple Health integration, while the EvieMED Ring is FDA 510(k)-cleared for clinical-grade pulse oximetry. Movano's proprietary RF chip enables miniaturized, accurate biometric sensing without traditional cuffs or continuous calibration. The company advances clinical validation through partnerships with health researchers and ongoing FDA-regulated clinical studies to expand approved indications for glucose and blood pressure monitoring.

FuzeRx (operated by Truepill) is a URAC-accredited pharmacy and telehealth platform specializing in end-to-end digital pharmacy solutions for Life Sciences companies, payers, healthcare providers, and consumer health brands. The platform offers configurable APIs and white-label technology designed to streamline prescription fulfillment, patient management, and clinical data handling. FuzeRx provides three primary service models: Virtual Pharmacy (all-in-one platform combining hub and dispensing), Hub+ (automation-driven pharmacy hub with improved patient access and adherence), and Dispensing (specialty and brand medication fulfillment with nationwide 50-state shipping and same-day courier options). The platform processes over 25M prescriptions for 6M+ patients with 41% processed within 2 minutes. Deep therapeutic expertise spans women's health, endocrinology, and immunology. Features include configurable patient safety APIs for drug utilization reviews, customizable health questionnaires, insurance and FSA/HSA payment processing, custom branded packaging, and comprehensive data dashboards. URAC-accreditation ensures compliance with pharmacy and specialty pharmacy standards.

Advantech Corporation is a global leader in embedded computing, industrial automation, edge AI, and intelligent healthcare solutions. The company manufactures industrial-grade computing platforms, edge AI systems, IoT devices, and healthcare-specific IT infrastructure. Product lines include embedded PCs, fanless computers, edge AI and GPU systems, industrial motherboards, medical computers and tablets, medical monitors, and operating room video solutions. Advantech also provides intelligent healthcare platforms (iHospital), medical carts and tablets, and comprehensive design-to-order manufacturing services. The company serves industrial, healthcare, retail, logistics, and transportation sectors with solutions for edge computing, data acquisition, automation control, and healthcare IT infrastructure. Advantech offers design and manufacturing services, global technical support, RMA services, training through IoT Academy, and a comprehensive eStore for procurement. The company emphasizes reliability, industrial-grade specifications, and integration with industry standards.

DT Research, Inc. is a Silicon Valley-based industrial computing manufacturer founded in 1995, specializing in purpose-built rugged computing systems for healthcare, government, and enterprise environments. The company designs and manufactures medical tablets, medical cart computers, medical all-in-one systems, rugged convertible laptops, and digital signage solutions. All medical products carry ANSI/AAMI ES60601-1 certification and feature antimicrobial coatings. DT Research emphasizes deployment-ready, customized solutions with integrated software and hardware, rigorous testing, and assembled-to-order manufacturing. The company provides device management software, fleet management tools (WebDT Battery Fleet Manager), and long-term support services. With engineering teams and production facilities across California and Asia, DT Research serves hospitals, military, government agencies, and logistics/manufacturing sectors worldwide.

Cognita Labs is a medical device innovator founded by Rice University researchers, focused on simplifying pulmonary diagnosis and management. The company develops an integrated ecosystem of FDA-cleared, mobile-first devices and cloud platforms for respiratory care that bridge clinical and home settings. Products include PulmoScan (portable airway impedance testing), CapMedic (intelligent inhaler attachment with home spirometry), and UltraSpiro (coaching spirometer). Solutions enable remote patient monitoring, real-time inhaler technique feedback, and data-driven clinical decision-making. Designed for high-volume clinics, pediatric practices, and underserved populations where access to traditional pulmonary function testing is limited.

ZOLL Medical Corporation manufactures an integrated portfolio of medical devices, software, and services focused on emergency care, cardiac resuscitation, and patient monitoring. The company serves EMS and fire departments, hospitals, military organizations, public safety agencies, and non-acute care settings including dental and physician offices. Core product lines include automated external defibrillators (AEDs), professional monitor/defibrillators (Zenix), wearable defibrillators (LifeVest), ventilators, CPR feedback and automated CPR devices, and implantable cardiac management systems (remedē System for central sleep apnea). ZOLL also offers comprehensive software and data analytics solutions for EMS/fire operations and hospital administration through ZOLL Data Solutions, addressing billing optimization, documentation, and clinical performance management. The company owns or partners with ZOLL Itamar, a leader in sleep apnea diagnosis and management. Products feature Real CPR Help technology, intuitive interfaces, configurable clinical parameters, and integrated data collection for continuous quality improvement. ZOLL emphasizes clinical training, education platforms (E-Learning), and continuous product support. The company is part of Asahi Kasei and maintains FDA clearances, EU MDR approval, and established regulatory standing across markets. Serves diverse customer bases from lay rescuers and community organizations to hospital systems and military medical units.

Dentis USA Corporation is a global manufacturer of comprehensive dental and medical solutions, founded in 2005 and operating in over 80 countries. The company specializes in dental implants and implant systems, including the emerging AXEL line and SQ mini implant technologies. Beyond implantology, Dentis offers integrated solutions across digital dentistry (CAD/CAM, guided implant surgery systems, 3D printing), equipment and clinic solutions (surgical kits, dental units, surgical lighting), and advanced biomaterials for enhanced clinical outcomes. The company operates three strategic divisions: Dentis (core dental/medical solutions), Luvis (clinical and surgical solutions), and Global Dental Implant Academy (GDIA), an established surgical training provider offering live patient implant training and professional education. Dentis serves dental professionals, clinics, and hospitals with a focus on innovation, clinical evidence, and practitioner development.

ImpediMed is a medical technology company specializing in bioimpedance spectroscopy (BIS) devices for noninvasive clinical assessment and monitoring of fluid status and tissue composition. The company's flagship SOZO® Digital Health Platform is FDA-cleared and enables real-time measurement of body composition, fluid volumes, and tissue changes across multiple clinical applications. Primary use cases include early detection and monitoring of secondary lymphedema in cancer survivors, heart failure fluid management, medical weight management assessment, and wellness/longevity monitoring. The SOZO platform utilizes advanced BIS technology measuring 256 frequencies to separate intra- and extracellular fluid and deliver actionable insights at point of care. The company operates a cloud-connected SaaS model supporting personalized care monitoring across the patient treatment continuum, with global distribution in US, Europe, Australia, and other markets.

Pearl Inc. is a dental AI software company providing FDA-cleared diagnostic and practice management tools for dental clinics globally. The company develops artificial intelligence solutions that analyze 2D X-rays and 3D CBCT imagery to support radiologic diagnosis, enhance patient communication, optimize clinical workflows, and improve revenue cycle management. Pearl's core products include Second Opinion (pathology detection in dental X-rays), Second Opinion 3D (CBCT analysis for specialists and general dentists), Practice Intelligence (data analytics for practice growth), Precheck (automated insurance verification and cost estimation), Calibrate (AI-guided clinical training), and Pearl Voice (ambient voice AI for clinical documentation and periodontal charting). The platform integrates with 40+ dental practice management and imaging systems including Eaglesoft, Dentrix Ascend, Dolphin, Carestream, Romexis, Vatech, Apteryx, and others. Pearl serves over 23,000 dental practices across 120+ countries and holds 26+ regulatory clearances. The company is FDA-cleared for diagnostic support workflows and claims to help practices increase treatment acceptance by 30%, detect 37% more disease, deliver 24% more care, save 20+ hours per week in operational time, and boost monthly production by $30K. Target markets include general dental practices, specialists, dental schools, and DSO networks. Pearl positions itself as dentistry's leading AI platform with emphasis on clinical validation, transparent reporting, and seamless EHR/imaging system integration.

Signos is an AI-powered metabolic health platform that combines continuous glucose monitoring (CGM) with personalized weight management guidance for non-diabetic and metabolically-conscious consumers. The platform integrates Dexcom G7 CGM sensors with a proprietary mobile application that uses machine learning to analyze glucose patterns and predict individual metabolic responses to food, exercise, sleep, and stress. Members receive real-time glucose tracking, personalized eating and movement recommendations, registered dietitian support, and weekly metabolic reporting. The service is FDA-cleared and HSA/FSA-eligible, offered through direct consumer channels and employer-sponsored wellness programs. Clinical outcomes show 86% of members report success in their first month, with significant weight loss and improved metabolic stability.

Avive Solutions Inc manufactures connected automated external defibrillators (AEDs) and integrated cardiac arrest response systems for out-of-hospital cardiac arrest (OHCA) management. The company's flagship Avive Connect AED® device pairs powerful hardware with REALConnect™ software services, enabling real-time AED connectivity, 911 integration via Intelligent Response™, and rapid incident data transfer including ECG waveforms, usage timestamps, and shock analysis. Avive's 4 Minute Community™ program provides consultative community assessments and coordinated deployment strategies to bridge the chain of survival across bystanders, 911 dispatch, first responders, and hospital care. The solution addresses the critical gap in AED utilization—currently used in only ~2% of OHCA cases despite survival rates increasing to 53% when deployed by bystanders prior to EMS arrival. Avive serves school districts, municipalities, police departments, universities, athletic facilities, and healthcare networks across the United States. The company offers both hardware (Avive Connect AED devices with wall-mount options) and cloud-based software managing device status, maintenance scheduling, and emergency response coordination. Regulatory status and certifications not explicitly stated on site but implied through medical device market positioning. Customers include Forsyth County GA, Northern Kentucky police departments, and Cumberland County PA public health systems.

Broadata Communications, Inc. (BCI) is a California-based medical device manufacturer specializing in professional AV connectivity and display solutions for healthcare and high-performance environments. Founded in 2000 and ISO 13485 certified, BCI delivers fiber optic video transport systems, HD-BaseT converters, HDMI 4K matrix switches, and medical-grade display technology including 32" 4K surgical displays and wireless monitor stands. The company provides comprehensive design engineering, kitting, and box build manufacturing services for demanding medical applications requiring reliable signal transmission over fiber, IP-based, and coaxial infrastructure. BCI has deployed over 500,000 products globally and serves medical facilities, surgical centers, defense, government, education, and entertainment sectors. Its core competency lies in engineered AV systems integration for operating rooms, diagnostic imaging, and telemedicine environments where signal integrity and compliance are mission-critical.

Twist Bioscience Corporation is a US-based synthetic biology company specializing in DNA-based research tools and services. The company operates a proprietary semiconductor-based synthetic DNA manufacturing platform utilizing high-throughput silicon technology for miniaturized chemistry and cost-efficient DNA synthesis. Core product portfolio includes synthetic genes (clonal genes, gene fragments, gene pools, vectors), oligonucleotide pools (cloned and uncloned), next-generation sequencing (NGS) target enrichment solutions, library preparation kits (including TrueAmp Library Prep Kit and PCR-free WGS kits), variant libraries (combinatorial, site saturation, spread-out low diversity), and synthetic controls for infectious disease and liquid biopsy applications. The company also offers comprehensive antibody discovery and development services including in vitro phage display, in vivo discovery using Diversimab technology and humanized transgenic mice, antibody characterization (SPR, developability assessment, functional assays), and optimization services including AI/ML-driven affinity maturation and in silico humanization. Twist Service Lab provides outsourced sequencing services, and the company offers automation solutions and API-based procurement integration. Target markets include academic research, pharmaceutical drug discovery, cancer research, infectious disease research, agricultural biotechnology, and clinical diagnostics. The platform enables researchers to access customizable gene synthesis at varying scales, perform high-confidence genomic screening, and conduct precision variant detection across NGS workflows.

SOTA Imaging is a dental imaging equipment manufacturer with over 30 years of industry experience. The company specializes in digital intraoral and sensor-based dental imaging solutions, offering products designed for seamless integration with leading dental practice management and imaging software platforms including Dexis and Eaglesoft. SOTA's core product line includes Clio Prime digital X-ray sensors, Claris i5HD intraoral cameras, and SOTA Cloud, a cloud-based imaging management platform. The company emphasizes agile, modular dental imaging with durable construction and advanced sensor technology. SOTA Imaging provides technical support including free installation, training, and ongoing software integration assistance. Products are compatible with most major dental software ecosystems, addressing the integration challenges faced by multi-platform dental practices. The company serves dental practices seeking modern imaging capabilities without the complexity of legacy systems. Manufacturing focus includes imaging sensor design, digital capture technologies, and cloud-based image storage and retrieval solutions.

Gojji is a chronic disease management platform that delivers remote monitoring and personalized care support for patients with diabetes, hypertension, high cholesterol, and related conditions. The company operates a whole-person care and population health program aligned with payors and primary care providers to bridge gaps between clinical visits. Gojji's service model includes real-time glucose monitoring via personal meters, telephonic care coordination, dietary guidance, medication management, and continuous health tracking accessible through a patient portal. The platform integrates with healthcare systems and supports multiple chronic disease prevention programs including diabetes prevention, obesity/weight management, and asthma/COPD management. Gojji serves community health centers, federally qualified health centers (FQHCs), and health plans across California, with particular strength in Medi-Cal populations. The company provides multilingual support (12+ languages) and operates business hours Monday–Friday, 8:00 AM–6:00 PM. Patient testimonials emphasize improved blood sugar control and empowered self-management through frequent monitoring and personalized coaching. Gojji's clinical model emphasizes individualized experiences, real-time data visibility, and collaborative care between patients, primary care physicians, specialists, and payors to shift populations toward improved health outcomes.

VitalConnect, Inc. is a remote patient monitoring company specializing in wearable cardiac monitoring devices and integrated telehealth software. The company manufactures the VitalPatch®, an adhesive wearable sensor that continuously monitors electrocardiography (ECG) and multiple vital signs (up to 11 parameters) for patients in hospital and home settings. The VitalPatch RTM (Remote Telemetry Monitoring) is a first-of-its-kind extended Holter monitor technology enabling real-time cardiac data streaming. VitalConnect's integrated software solution combines live ECG monitoring with telehealth-enabled platforms for synchronized clinical review and decision support. Primary markets include remote patient monitoring, hospital-at-home programs, post-discharge cardiac surveillance, and COVID-19 patient monitoring to minimize caregiver exposure while maintaining continuous clinical oversight. The company has demonstrated significant adoption acceleration since 2020, driven by telehealth expansion and remote monitoring adoption in acute care settings. VitalConnect products support both in-hospital and at-home monitoring workflows. The TELESTAR-TAVR clinical study demonstrates clinical validation efforts for transcatheter aortic valve replacement monitoring. The company targets hospital systems, cardiology practices, and home health providers requiring continuous, accessible cardiac monitoring without traditional Holter monitor limitations.

Cala Health is a bioelectronic medicine company specializing in wearable neuromodulation therapies for chronic diseases. Founded in 2014 as a Stanford University spinout, Cala develops non-invasive peripheral nerve stimulation devices using transcutaneous afferent patterned stimulation (TAPS). The company's flagship product, the Cala kIQ, is an FDA-cleared wrist-worn device for reducing action hand tremor in essential tremor and Parkinson's disease patients. The Cala kIQ delivers on-demand TAPS therapy with clinically proven efficacy—patients report tremor reduction within 40 minutes, with relief lasting over 90 minutes post-session. The company supports a comprehensive patient lifecycle ecosystem including prescription fulfillment, insurance reimbursement assistance, connected care services via MyCala.com patient portal, telemedicine consultation, and medication management support. Medicare and VA coverage are available for qualifying beneficiaries. Cala Health is expanding its therapeutic focus to neurology, cardiology, and psychiatry applications.

Digicom Electronics, Inc. is a certified Small Business electronics manufacturing services (EMS) provider operating from Oakland, California since 1982. The company specializes in printed circuit board assembly (PCBA), box-build systems, cable harnesses, and contract electronics manufacturing for highly regulated industries including aerospace, defense, medical devices, industrial controls, telecommunications, and railways. Core capabilities span procurement and materials management, surface-mount and through-hole PCB assembly, selective soldering, functional testing, burn-in validation, optical and X-ray inspection, and full turnkey or consignment manufacturing with program management. Digicom is AS9100:2016 (Rev D) aerospace certified, ISO 9001:2015 and ISO 13485:2016 medical device certified, ITAR registered, and compliant with 21 CFR 820. The company serves prototype and low- to mid-volume production runs with rapid quoting (2–5 business days). As a subsidiary of Kaynes Technology Group, Digicom provides access to global supply chain resources while maintaining U.S.-based assembly and quality control. The facility includes advanced SMT lines, flexible circuit and RF assembly capabilities, warehousing, and fulfillment services. Notable projects include partnering with CASPER and radio astronomy institutes on the ROACH system hardware that enabled the first image of a black hole.

EchoPixel develops a software platform that converts standard medical imaging data into interactive 4D holographic visualizations for surgical planning and intraoperative guidance. The platform creates patient-specific digital twins that physicians experience as real physical objects without requiring headgear or glasses, enabling precise visualization of complex anatomical relationships during minimally invasive procedures. The technology is particularly applied in structural heart and congenital heart interventions, providing real-time situational awareness of catheters and implantable devices relative to patient anatomy. The company's core offering addresses limitations of traditional 2D and 2.5D imaging by reducing procedure complications and expanding access to minimally invasive therapies. EchoPixel's solution is FDA 510(k) cleared and deployed in leading hospital systems. The platform serves as a turnkey surgical guidance system that integrates with existing hospital imaging workflows, designed for cardiology, interventional radiology, and cardiac surgical teams. Manufacturing and software development capabilities are based in San Jose, California.

IEI Integration Corp. is a Taiwan-based edge computing and embedded systems manufacturer specializing in AI-ready industrial computers, fanless systems, and medical-grade solutions. The company designs and manufactures box PCs, panel PCs, embedded systems, network appliances, and specialized medical imaging capture systems. IEI offers an ODM (Original Design Manufacturing) service for custom embedded computing solutions across multiple verticals including healthcare, smart factories, autonomous mobile robots, and networking infrastructure. The company holds TFDA (Taiwan FDA) and ISO 13485 certifications for medical device manufacturing, demonstrating compliance with international medical device quality standards. Product lines include the HTB series (medical AI box PCs with 24-core processors and touchscreen displays), TANK AIoT developer kits, PUZZLE network appliances, and the EndoCap-3588 endoscopic image capture and recording system designed for medical visualization and diagnostics. IEI supports Intel and AMD processors, GPU acceleration (Nvidia Quadro RTX), real-time computing with Intel TCC/TSN, and integrated AI inference via OpenVINO and Intel Movidius Myriad X accelerators. The company manufactures in Taiwan with new facility expansion in Yangmei and maintains a US presence through IEI Technology USA Corp. Services include technical support, warranty coverage, software services, and end-of-life product management. IEI serves OEMs, medical device manufacturers, industrial automation integrators, and healthcare facilities requiring edge AI computing, real-time data processing, and ruggedized embedded platforms.

Masimo Corporation is a global leader in noninvasive patient monitoring solutions, specializing in innovative pulse oximetry, vital sign monitoring, and brain function monitoring technologies. Founded on breakthrough accuracy in pulse oximetry (Masimo SET®), the company develops and manufactures continuous monitoring systems for hospitals, ICUs, operating rooms, and neonatal care settings. Core product lines include Masimo SET® Pulse Oximetry for continuous, accurate oxygen saturation measurement across all patient populations and clinical settings; SedLine® Brain Function Monitoring for depth-of-anesthesia and sedation monitoring; Masimo O3® Regional Oximetry for tissue oxygenation assessment with FDA-cleared hemoglobin parameters; and Root® Patient Monitoring and Connectivity Platform, a modular hospital automation system integrating vital signs, connectivity, and clinical workflow solutions. Masimo technologies are deployed across acute care, perioperative, emergency, neonatal, and general floor environments. The company holds over 900 patents globally and serves leading hospitals and healthcare systems in 30+ countries. Known for motion-artifact rejection and performance accuracy across diverse patient populations, Masimo's solutions address clinical needs in congenital heart disease screening, critical care monitoring, anesthesia management, and cost reduction through early patient distress detection. The company emphasizes sustainability and has strategic partnerships with major healthcare technology providers including Philips. Acquired by Danaher in February 2026.

Zepp Health is a consumer health technology company delivering smart wearable healthcare solutions and digital health management platforms. The company manufactures intelligent wearables including smartwatches, smart bands, and smart hearing devices capable of continuous 24/7 health monitoring and biometric data collection. The Zepp Digital Health Management Platform integrates proprietary Zepp OS, AI chips, biometric sensors, and data algorithms to provide cloud-based actionable health insights and personalized wellness guidance. Key capabilities include real-time physiological monitoring, AI-driven sports and sleep coaching, atrial fibrillation detection (with 135,000+ suspected AFib events detected), and generative AI solutions utilizing Large Language Models for natural language interaction. The platform delivers preventative care insights and enables users to understand their health data for informed decision-making. Zepp Health serves a global consumer market with 42+ million active users across 90+ countries and has shipped over 200 million units worldwide. The company collaborates with 25+ world-class research partners and combines audiologist expertise with wearable technology for hearing solutions. Products feature proprietary sensors and algorithms optimized for continuous health tracking, fitness monitoring, sleep analysis, and wellness optimization across consumer segments.

OrthoRPM Inc. manufactures Dexterity, a smart connected hand therapy device for remote patient monitoring and rehabilitation. The system provides individual digit assessment and therapy for fingers and grip strength, enabling patients to perform therapy at home while licensed therapists and physicians monitor progress in real-time through a connected portal. The platform includes a patient-facing mobile application for exercise tracking and data submission, and a therapist/physician portal for patient management, result visualization, and clinical oversight. OrthoRPM targets hand therapy specialists, occupational therapists, physical therapists, orthopedic surgeons, and hand surgery practices seeking to deliver remote therapeutic monitoring and improve patient compliance and functional outcomes. The company focuses on converting traditional, in-clinic hand grip assessment and therapy into digitally connected, home-based care. Regulatory status, specific FDA clearances, and manufacturing certifications are not disclosed on the site.

Tidepool is a digital health platform that aggregates and visualizes diabetes management data from multiple device manufacturers into a unified, cloud-based system. The company provides software solutions for patients, caregivers, and healthcare providers to securely upload, access, and analyze continuous glucose monitoring (CGM) data, insulin pump data, and blood glucose meter readings from devices manufactured by Medtronic, Tandem, Omnipod, Dexcom, Abbott FreeStyle Libre, and numerous other diabetes device makers. Tidepool offers three primary software products: Tidepool Uploader (desktop application for data synchronization), Tidepool Mobile (patient-facing app for device pairing and data review), and Tidepool Data Platform with a Population Health Dashboard for healthcare provider insights. The company also develops Tidepool Loop, a closed-loop automated insulin delivery system derived from the open-source Loop community, distributed commercially by Sequel Medical Technologies as twiist Loop. Tidepool serves patients managing type 1 and type 2 diabetes, healthcare providers including endocrinologists and primary care physicians, telemedicine platforms, and diabetes researchers. The platform integrates real-time data from 40+ compatible devices and emphasizes accessible, actionable insights to improve glycemic control and reduce diabetes management burden. Tidepool supports HIPAA-compliant data sharing and serves the US market with focus on accessibility and interoperability across the diabetes device ecosystem.

Applied Science, Inc. develops regulated medical devices and SaaS platforms serving blood collection and chronic care management markets. The company operates two primary business lines: HemoFlow, an automated whole blood collection system for blood banks, and AdaptivMD, a remote patient monitoring and chronic care management platform. HemoFlow provides mixers, software services, and consumables to optimize transfusion medicine workflows, enabling automated paperless collection, error and waste reduction, enhanced phlebotomist productivity, and centralized device management across blood collection facilities. The platform processes approximately 18 million whole blood donations annually, supporting 54 million transfused blood products globally, with 99.74% customer retention over 13 years. AdaptivMD serves community and rural healthcare providers with value-based care solutions, incorporating remote patient monitoring, telehealth, diabetic retinopathy screening, painless blood glucose monitoring, chronic care management, and EHR-integrated workflows to improve health equity for underserved populations. The company has delivered regulated devices and SaaS services for over 15 years to private and public blood banks worldwide. Applied Science emphasizes interoperability, seamless integrations, and automation efficiencies across its platform portfolio. Service capabilities include passionate, experienced, and agile customer support.

Circadia Technologies develops FDA-cleared continuous monitoring and predictive analytics solutions for senior care facilities and payers. The company manufactures the Circadia C200, a contactless radar-based early detection device that monitors heart rate, respiratory rate, bed exits, and patient motion. The C200 integrates with Circadia's proprietary Clinical Intelligence Platform, which uses machine learning and AI to generate real-time alerts and daily risk reports to prevent rehospitalizations and identify fall risks. The platform is marketed as a predictive care solution for skilled nursing facilities (SNFs), assisted living, and other senior care settings. Circadia's technology is Medicare-reimbursable and deployed across major healthcare providers. The company reports monitoring 30,000+ patients daily, with demonstrated outcomes including 30% reduction in rehospitalizations after 12 months and 78% sensitivity for detecting preventable hospitalizations. The C200 is FDA-cleared for its specified vital sign and motion detection capabilities. Circadia serves a network of senior care operators, health systems, and payers with contracted ROI models ($316K yearly per 100-bed SNF for providers; $864K for payers). The company combines hardware (radar-based sensor), software (analytics platform), and clinical services to deliver comprehensive preventive care solutions.

LifeSignals, Inc. is a medical device company specializing in wireless patient monitoring solutions and disposable wearable biosensors for in-hospital, hospital-at-home, and ambulatory care settings. The company develops the UbiqVue™ platform, a cloud-based wireless patient monitoring system that captures continuous vital signs including 2-channel ECG and multiparameter vital signs through single-use, cost-effective biosensors. LifeSignals' patented LSP silicon platform enables disposable sensors designed for mass production, reducing clinical device costs while maintaining clinical-grade accuracy. The UbiqVue Multiparameter system provides near real-time vital sign monitoring for large-scale in-hospital and hospital-at-home delivery; the UbiqVue Holter system delivers cloud-based ECG analysis and reporting for ambulatory cardiac services and mobile cardiac telemetry (MCT). Core technology includes Wi-Fi-centric wireless connectivity with support for multiple radios, HIPAA and GDPR-compliant data transfer, and robust encryption. The company serves healthcare providers, integrated delivery networks, and digital health platforms seeking to untether patients from wired monitoring constraints while enabling data-driven clinical insights. LifeSignals operates manufacturing and integration capabilities with headquarters in Milpitas, CA, and regional offices in India, Europe (Ireland), and Asia-Pacific (Singapore), supporting global deployment of wireless healthcare monitoring infrastructure across population health initiatives.

Previon Solutions is a healthcare integration and compliance technology company serving health plans, managed care organizations, and healthcare systems. The company specializes in streamlining administrative and clinical programs through centralized software platforms and fulfillment services. Their core offerings include Previon PrISM, a campaign management platform designed for deploying repeatable program performance in preventative care initiatives; Previon Compliance™, which automates CMS-regulated document fulfillment and communication compliance; and white-labeled self-collection diagnostic kits that enable preventative care through at-home testing. Previon also provides assembly and fulfillment services, outreach solutions, and ongoing client support. The company operates on a consulting and implementation model, beginning with client consultation to understand desired outcomes, followed by comprehensive solution design including materials, branding, and engagement workflows. Staff training and post-implementation support are standard components of their service delivery. Previon serves diverse healthcare segments including virtual care organizations, managed care administrators, and health plans. The company is recognized as a top workplace in Orange County and maintains a client base that values ease of use, compliance automation, and responsive customer service.

UpDoc is a Remote Patient Intervention (RPI) platform combining agentic AI with physician oversight to deliver proactive, evidence-based care for chronic disease management. The platform enables continuous, personalized patient monitoring and intervention between clinical visits through EHR integration and mobile application interfaces. UpDoc's technology operates under physician supervision, automatically monitoring patient metrics (including blood glucose and other chronic disease indicators), driving timely patient engagement, and triggering clinical escalations before deterioration occurs. The platform is designed to increase medication adherence, improve chronic disease outcomes, and expand clinical capacity without proportional increases in labor costs. Clinical validation, published in JAMA Network Open, demonstrated 3x improvement in chronic disease metrics, 65% increase in medication adherence, and 5x expansion of clinical capacity using equivalent staffing. The system targets healthcare organizations, health plans, employers, and healthcare systems seeking to address care gaps between patient visits and reduce both clinical burden and total cost of care. UpDoc is trusted by major medical institutions including Mayo Clinic, UCSF, and University of Minnesota, and has backing from technology and healthcare leaders.

Omada Health is a virtual-first digital therapeutics and care management platform specializing in chronic condition management through evidence-based programs, personalized health coaching, and connected smart devices. Founded in 2011, the company delivers integrated care pathways for prediabetes/weight management, diabetes, hypertension, and musculoskeletal conditions, serving over 1,700 employer and health plan customers covering more than 1 million members. The platform combines behavioral science, one-on-one coaching from certified specialists, continuous monitoring via smart devices (scales, blood pressure monitors, glucose meters, CGM sensors), interactive digital lessons, and peer support communities. Omada integrates data with primary care providers and uses a multidisciplinary clinical and data science approach to drive measurable health outcomes and ROI, with documented savings of $983+ per member in the first year and 88%+ customer satisfaction on cardiometabolic programs.

Intuitive Surgical, Inc. is a global leader in robotic-assisted surgical systems and digital health solutions. The company manufactures the da Vinci family of robotic surgery platforms, which enable minimally invasive surgical procedures across multiple specialties including general surgery, urology, gynecology, cardiothoracic, and orthopedics. Core product lines include the da Vinci 5 (advanced integrated robotic platform with surgeon console and patient cart), the da Vinci SP (single-port robotic system for new surgical approaches), and the Ion robotic bronchoscopy system for lung cancer diagnosis and biopsy. Intuitive also manufactures da Vinci instruments and accessories designed for precision and ergonomic control. Beyond hardware, the company provides digital solutions including My Intuitive (data analytics and insights platform for surgical teams) and SimNow (surgeon training and simulation software). The company operates a global infrastructure with expanded direct operations in Europe and provides 24/7 service and support. Intuitive's systems are used in hospitals worldwide for minimally invasive surgery, and the company has established itself as the market leader in robotic-assisted surgical technology since its founding in 1995. The platform emphasizes surgeon autonomy, precision, and patient outcomes through advanced visualization and control systems.

Siren is a digital health and remote patient monitoring company specializing in smart textile technology for chronic disease management. The company manufactures FDA-registered Siren Socks, wearable temperature-monitoring devices embedded with microsensors that detect early signs of foot inflammation in patients with diabetes and neuropathy. The socks wirelessly transmit data to a monitoring platform where licensed nurses review metrics and alert healthcare providers to potential injuries, enabling early intervention to prevent diabetic foot ulcers. Siren's integrated care management service includes device delivery, continuous nurse-led monitoring, provider alerts, and clinical decision support. The platform operates without requiring smartphone connectivity and features machine-washable, auto-replacing sock technology. The company serves high-risk diabetic populations through partnerships with the US Department of Veterans Affairs and healthcare networks nationwide, focusing on reducing preventable amputations and hospitalizations through proactive foot health surveillance.

Qisda Corporation is a global technology conglomerate founded in 1984, headquartered in Taiwan. The company operates across five major business segments: displays, projectors, medical devices, smart solutions, and networking services. In the medical sector, Qisda has developed a diversified medical fleet (醫療艦隊) encompassing six key domains: medical equipment, medical consumables, hemodialysis, medical imaging, health & wellness devices, and medical services. The company owns two large integrated hospitals and operates as both a medical device manufacturer and healthcare distribution provider. Qisda is recognized as a Thomson Reuters Global Tech 100 leader, an Asia Best Employer, and a Taiwan Top 10 Sustainability Enterprise. In displays, Qisda ranks as the world's second-largest LCD panel manufacturer, serving consumer, commercial, professional, and medical applications. In projectors, the company ranks in the global top three, holding the second-largest market share in DLP projection technology. The medical business serves first-line healthcare users with integrated solutions across hospital infrastructure, clinical diagnostics, renal therapy, imaging systems, consumer health products, and healthcare management services. Smart solutions span six verticals: smart retail, smart healthcare, smart energy, smart manufacturing, smart enterprise, and smart education, emphasizing hardware-software integration and one-stop provisioning. The networking division provides comprehensive broadband services including wired/wireless networks, broadband infrastructure, systems integration, and 5G enterprise private networks. Qisda operates manufacturing facilities and sales offices across 60+ countries with approximately 30,000 employees.

Applied Spectral Imaging (ASI) is a global leader in digital pathology and cytogenetics solutions with a three-decade legacy in biomedical imaging. The company develops computer-aided diagnostic software and imaging systems for brightfield, fluorescence, and spectral microscopy analysis. ASI serves clinical pathology and cytogenetic laboratories across 80+ countries through a network of distribution partners, including major academic medical centers (Cleveland Clinic, Duke, Montefiore). Core product lines include digital cytogenetics platforms for aided karyotyping and FISH (fluorescence in situ hybridization) scanning and analysis, and digital pathology solutions for H&E and immunohistochemistry (IHC) imaging with scanner-agnostic capabilities. Key software offerings include HiPath Pro for PD-L1 immunostaining interpretation and analysis, and metaphase finder/slide loader automation systems for increasing laboratory throughput and diagnostic accuracy. The company emphasizes integration of brightfield and fluorescence imaging modalities, tissue specimen matching, and user-centric design. ASI's solutions target improved inter- and intra-observer consistency, technologist productivity, and diagnostic confidence in cytogenetic and pathology workflows.

ProperGuide Implant is a full-service dental laboratory and education company headquartered in San Leandro, California, specializing in precision dental implant restorations and clinical training. The company manufactures custom abutments, implant-supported crowns, bridges, and all-on-X prosthetics using in-house CAD/CAM digital workflows and milling capabilities. As an official OEM partner of Hiossen implant systems, ProperGuide provides certified restorations with guaranteed compatibility and quality. Beyond laboratory services, the company operates an elite clinical education program offering live implant surgery courses and hands-on mentorship for dentists entering implant surgery practice. Their service portfolio includes surgical guide fabrication, smile design planning, digital wax-ups, and nightguard fabrication. With over 10 years in business, a <2% remake rate, and partnerships with advanced surgical programs at Stanford, ProperGuide serves dentists requiring precision digital planning and reliable restorative solutions for complex single-tooth and full-arch implant cases.

Bodyport Inc. is a biomarker-guided digital therapeutics company specializing in remote monitoring solutions for complex chronic conditions, particularly heart failure. The company's FDA-cleared Bodyport Cardiac Scale (Fluiditi™) is a non-invasive, at-home device that measures hemodynamic biomarkers—including heart function and fluid status—through advanced sensors embedded in a bathroom scale. Patients simply step on the device for under 30 seconds, and data transmits via cellular connection to care teams within minutes. The proprietary Congestion Index algorithm combines multiple hemodynamic biomarkers into a composite metric for early detection of worsening heart failure, demonstrating superior performance over traditional weight-based monitoring in clinical validation. Bodyport's integrated care platform combines a clinical portal with a patient app, delivering actionable insights for timely clinician interventions. The system supports RPM billing, integrates via API with leading EHRs, and maintains HIPAA compliance and SOC 2 certification. The company partners with major health systems including Geisinger, Stanford, Duke, and Brigham & Women's Hospital, backed by peer-reviewed clinical evidence published in leading medical journals.

Compumedics Limited is a world-leading designer and manufacturer of diagnostic and research technologies for sleep, neurodiagnostics, brain research, and ultrasonic blood flow monitoring. Founded in 1987 and listed on the Australian Securities Exchange (ASX: CMP) since 2000, the company has established itself as a primary supplier of polysomnography (PSG) systems, EEG amplifiers and recorders, and magnetoencephalography (MEG) equipment. The product portfolio includes comprehensive sleep diagnostics solutions spanning in-lab, home-based, ambulatory, and wireless configurations, as well as complete neurodiagnostic platforms supporting clinical EEG, long-term monitoring (LTM), ICU continuous EEG (cEEG), and high-channel-count research applications. The company offers proprietary software platforms—Profusion Sleep, Profusion EEG, Profusion neXus 360 for laboratory management, and CURRY for advanced brain analytics—alongside supporting accessories and consumables. Compumedics operates a global infrastructure with corporate headquarters in Abbotsford, Australia, and major regional hubs in Charlotte, North Carolina (USA), Dresden and Freiberg (Germany), Strasbourg (France), and Shenzhen (China). The company maintains over 15% investment in R&D and holds a Medical Advisory Board to ensure continued innovation. Products are distributed globally to clinical institutions, research centers, and pharmaceutical organizations conducting clinical trials. Regulatory credentials and specific certifications are not detailed in the accessible content, though the company's long operational history and ASX listing indicate substantial compliance infrastructure.

StarFish Medical is a medical device design and development consulting firm with 25+ years of experience and 200+ professionals serving the MedTech industry. The company provides end-to-end product development services including product design and development, new product introduction with commercialization focus, quality assurance, and regulatory affairs consulting. StarFish Medical helps medical device companies navigate complex regulatory landscapes and achieve market clearance. The firm serves startups through global enterprises across diagnostics, drug delivery, and therapy device sectors. Key capabilities include multidisciplinary in-house teams for concept-to-commercial-product transformation, clinical trial support, and tech transfer facilitation. The company has completed over 1,000 programs. Recently, StarFish Medical launched ELLA, an AI-powered regulatory compliance navigation tool designed specifically for medical device companies. The firm publishes extensive technical resources covering medical device topics including accelerated aging testing, remote device reliability, connected device architecture, GUI development efficiency, and regulatory classification. StarFish Medical is positioned as a regulatory and engineering consulting partner rather than a device manufacturer, supporting clients across diagnostics, drug delivery systems, and therapeutic devices intended for clinical and home-based use.

iHealth Labs Inc is a leader in consumer and clinical-grade home health monitoring devices founded in 2010. The company manufactures and distributes wireless vitals monitoring systems, rapid diagnostic tests, and telehealth-integrated solutions for patient self-management and remote patient monitoring (RPM). Product portfolio includes blood pressure monitors (Neo, Track Pro, 550BT models), wireless glucose monitors (Gluco+ system), pulse oximeters (Air Pulse), digital and infrared thermometers (PT1, PT3, PT5), and rapid diagnostic tests for COVID-19, influenza A/B detection. iHealth devices feature Bluetooth connectivity, cloud-based app integration (iHealth MyVitals), and clinical validation. The company holds FDA authorization for rapid test kits and has supplied millions of COVID-19 tests to the U.S. federal government. iHealth also operates iHealth Unified Care, a remote patient monitoring platform enabling Chronic Care Management (CCM) and RPM billing for healthcare providers. Products are FSA/HSA-eligible and sold direct-to-consumer and through healthcare systems. The company serves homecare, chronic disease management, and provider-based RPM markets with emphasis on ease of use, wireless connectivity, and integration with EHR/digital health workflows.

GCX Corporation is a US-based manufacturer of mobile medical workstations, patient engagement solutions, and healthcare furniture. The company specializes in ergonomic carts, roll stands, mounting systems, and tablet-based patient engagement platforms. Core product lines include EVO Carts (workstations-on-wheels with modular configurations), mounting hardware (arms, ceiling mounts, rail mounts, post mounts, counter-top mounts), tablet roll stands, and patient engagement overbed tables designed for telehealth and check-in workflows. GCX also manufactures OEM solutions for fetal monitoring carts and other specialized medical equipment configurations. The company offers comprehensive OEM services under ISO 13485 certification, including custom cart assembly, rapid prototyping, and equipment integration. GCX acquired Lilitab, a custom tablet kiosk platform for secure healthcare deployment. Products support HIPAA-compliant digital check-in, patient data management, and clinical workflows. The company maintains manufacturing and distribution facilities in North America (Petaluma CA headquarters, Franklin MA, El Paso TX) and international operations in Europe, the Middle East, Africa, and Asia-Pacific regions. GCX serves hospitals, clinics, and healthcare systems requiring mobile clinical workstations and patient-facing technology solutions.

Glidewell Dental is the world's largest dental laboratory and digital dentistry solutions provider, headquartered in Irvine, California. Founded in 1970, the company employs 4,300–5,000 professionals and delivers custom restorative dental prosthetics including crowns, bridges, dentures, and implants. Leveraging advanced digital workflows, 3D printing, and CAD/CAM milling technology, Glidewell specializes in high-quality, cost-effective solutions accessible to practitioners of all practice sizes. Flagship products include BruxZir Solid Zirconia restorations, Glidewell HT dental implants, Simply Natural Digital Dentures, and Comfort H/S bite splints. The company also offers glidewell.io, a comprehensive in-office milling and design suite for same-day restorations, alongside clinical support, continuing education (AGD PACE-certified), and research-driven innovations. Glidewell serves dentists globally through U.S. lab facilities and international offices, backed by a no-fault remake warranty and knowledgeable technical support.